Novamount Pharmaceuticals Private Limited
About Novamount Pharmaceuticals Private Limited
Data last updated:
Novamount Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2019PTC346641. Its GSTIN is 10AAGCN4321A1ZE (Bihar). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sulochna Devi and Mohit Goyal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 69 Bharat Vihar Kakrola Near Durga Mandir, New Delhi, Delhi, India – 110078.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.29 Lakh, a decline of 15% compared to the previous year. For the same year it recorded a net loss of ₹88,664 (net margin -16.7%) and EBITDA of -₹82,995 (EBITDA margin -15.7%). Revenue has declined at a compounded annual rate (CAGR) of 84% over three years and 14% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Novamount Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressA – 69 Bharat Vihar Kakrola Near Durga Mandir, New Delhi, Delhi, India – 110078
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Novamount Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Novamount Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Novamount Pharmaceuticals Private Limited, buy the company report.
Financials of Novamount Pharmaceuticals Private Limited
FY 2025 filings availableNovamount Pharmaceuticals Private Limited reported revenue of ₹5.29 Lakh (down 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 14% over five years, including a 15% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹82,995 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹88,664 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -15.7% | ||||
| Net Profit Margin | -16.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Novamount Pharmaceuticals Private Limited, buy the company report.
Board of directors of Novamount Pharmaceuticals Private Limited
Novamount Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sulochna Devi | Director | 01 Dec 2022 | 3 Years 10 Months | Current |
| Mohit Goyal | Director | 01 Dec 2022 | 3 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Novamount Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Novamount Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Novamount Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAGCN4321A1ZE | Bihar | Active | 10 Apr 2019 |
To see the full GST registrations and return filing status of Novamount Pharmaceuticals Private Limited, buy the company report.
Recent activity
Novamount Pharmaceuticals Private Limited has 6 board changes on record since 2020: 2 appointments and 4 cessations. The latest: Arun Kumar ceased to be Director on 01 Dec 2022.
Frequently asked questions
Novamount Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 February 2019 (7+ years old) and is registered under CIN U24239DL2019PTC346641.
Novamount Pharmaceuticals has 2 current directors:
- Sulochna Devi - Director
- Mohit Goyal - Director
The latest financial statements of Novamount Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Novamount Pharmaceuticals is 10AAGCN4321A1ZE, registered in Bihar. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Novamount Pharmaceuticals is U24239DL2019PTC346641. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Novamount Pharmaceuticals was incorporated on 27 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
Arun Kumar ceased to be Director on 01 Dec 2022. Gopal Singh ceased to be Director on 01 Dec 2022. Mohit Goyal was appointed as Director on 01 Dec 2022. Novamount Pharmaceuticals has 6 board changes on record in total.
The registered office of Novamount Pharmaceuticals is at A – 69 Bharat Vihar Kakrola Near Durga Mandir, New Delhi, Delhi, India – 110078.
Novamount Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Novamount Pharmaceuticals is compliant as of 29 August 2026. The company is actively filing with the Registrar of Companies.